In a Tokyo laboratory, researchers have coaxed simple photosynthetic bacteria into tiny factories, teaching them to produce a high-value material that has long relied on harvesting animals and seaweed. Assistant Professor Kaisei Maeda and his team at the Institute of Science Tokyo have demonstrated that sulfated polysaccharides—complex molecules prized in pharmaceuticals, cosmetics, and advanced materials—can now be grown in controlled cultures of engineered cyanobacteria instead of extracted from finite marine and animal sources.
The stakes are significant because these sulfated polysaccharides, known as SPS, are everywhere in modern manufacturing. Their unique physical and biological properties make them essential ingredients in everything from medical treatments to skincare products. Yet sourcing them from ocean organisms and animals raises urgent environmental concerns. The research published in Scientific Reports offers a path toward independence from those unsustainable supply chains.
The breakthrough came from a deceptively simple idea: if one species of cyanobacteria naturally produces these molecules, why not transfer that entire genetic instruction set into a different, more manageable species? Maeda's team identified the gene cluster responsible for producing synechan—a specific sulfated polysaccharide—in Synechocystis sp. PCC 6803 and transplanted it into Synechococcus elongatus PCC 7942, a cyanobacterium that normally produces no SPS at all. The results were immediate and clear. The engineered strain began secreting extracellular sulfated polysaccharides, proving that the complex genes could cooperate and function in their new home.
What makes this particularly elegant is that cyanobacteria are photosynthetic organisms, meaning they convert carbon dioxide directly into useful compounds using sunlight as their energy source. Unlike fermentation vats that rely on fed feedstocks, these engineered bacteria essentially manufacture themselves. "By introducing the full gene set into Synechococcus elongatus, we demonstrated that complex biosynthetic pathways can be reconstructed to function in a different cyanobacterial species," explains Maeda.
The research revealed something deeper, too. Microscopy and biochemical analysis confirmed that the engineered cells had adapted their entire metabolism to support this new task, shifting toward a stress-response state while prioritizing polysaccharide production. Gene activity patterns showed the introduced genes working in concert with the host organism's own cellular machinery. This insight matters because it provides a roadmap for future refinement—researchers can now target specific metabolic bottlenecks to improve yields and efficiency.
The implications ripple outward. Cyanobacteria could become what researchers call "cell factories," capable of producing not just sulfated polysaccharides but an expanding library of engineered biomaterials with customized properties. Synthetic biology techniques could allow scientists to tweak polysaccharide composition, optimize production, and design entirely new compounds tailored to specific industrial needs. All without depleting marine ecosystems or relying on animal farming.
For a world struggling to decouple advanced manufacturing from environmental extraction, the work represents a quiet triumph—proof that sustainable alternatives to resource-intensive industries are within reach. The journey from laboratory demonstration to industrial scale remains ahead, but the fundamental question has been answered: yes, we can grow these essential molecules differently. And in doing so, we might finally align human ingenuity with ecological responsibility.